The above chart presents the market trend analysis for usa pharmaceutical corp. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 117 transactions, with a transaction quantity of 2587234.16 and a transaction weight of 0.
YearTransactionsQuantityWeight
2025122525975678.6249093.3
20261172587234.160
Bill of lading data
<
1/15
>
Trade date
2026/03/28
B/L No.
kppe-sb-226794-28-03-2026
Suppliers
getz pharma pvt ltd.
Buyers
usa pharmaceutical corp.
POLs
kppe
PODs
——
Supply area
Pakistan
Purchas area
The Dominican Rep.
Product description
ASSORTED TABLETS (RISPLAR TAB/VASCULEXA-2.5 TAB/JARINU MET TAB/VILTREVAN-M TAB/VALENI TAB) (BATCH AND OTHER DETAIL AS PER INVOICE/PACKING LIST)
Expand
Trade date
2026/02/28
B/L No.
4082741
Suppliers
gland pharma ltd.
Buyers
usa pharmaceutical corp.
usa pharmaceutical corp. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as tablet,catheter,pharmaceutical product.
According to the 52wmb.com global trade database, as of 2026-03-28, the company has completed 3948 international trades,
with its main trading regions covering india,china,italy etc.
The core products include HS30049099,HS90183990,HS90189090 etc,
often transported via caucedo dominic rep.,port santo domingo, port caucedo dominic rep etc,
and its main trading partners are anqin kangmingna packaging co.ltd.,meril healthcare pvt ltd.,cipla s.a.c..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on usa pharmaceutical corp. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.